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The major group B coxsackievirus (CVB) recep-
tor is a component of the epithelial tight junction
(TJ), a protein complex that regulates the selec-
tive passage of ions and molecules across the
epithelium. CVB enters polarized epithelial cells
from the TJ, causing a transient disruption of TJ
integrity. Here we show that CVB does not in-
duce major reorganization of the TJ, but stimu-
lates the specific internalization of occludin—
a TJ integral membrane component—within
macropinosomes. Although occludin does not
interact directlywith virus, depletion of occludin
prevents CVB entry into the cytoplasm and in-
hibits infection. Both occludin internalization
and CVB entry require caveolin but not dyna-
min; both are blocked by inhibitors of macro-
pinocytosis and require the activity of Rab34,
Ras, and Rab5, GTPases known to regulate
macropinocytosis. Thus, CVB entry depends
on occludin and occurs by a process that com-
bines aspects of caveolar endocytosis with fea-
tures characteristic of macropinocytosis.
INTRODUCTION
Group B coxsackieviruses (CVB) are common human
pathogens that are transmitted by the fecal-oral route
and must cross the intestinal mucosa to initiate infection.
The intestines are lined by polarized epithelial cells, with
distinct apical and basolateral surfaces; intercellular tight
junctions (TJs) regulate the flow of ions and macromole-
cules, including viruses, across the intact epithelium (re-
viewed in Schneeberger and Lynch, 2004). The primary
CVB receptor, the coxsackievirus and adenovirus recep-
tor (CAR), is a transmembrane component of the TJ (Co-
hen et al., 2001). We previously found that CVB entry
into polarized epithelial cells depends on interaction with
a second receptor, decay-accelerating factor (DAF) on
the apical cell surface (Coyne and Bergelson, 2006). Virus
attachment to DAF triggers intracellular signals that permitCell Host & Mvirus to move to the TJ, interact with CAR, and enter the
cell by a caveolin-dependent, but dynamin-independent,
mechanism.
CVB entry from the TJ is accompanied by a transient
disruption of TJ barrier function (Coyne and Bergelson,
2006). TJs are composed of a complex of integral mem-
brane proteins whose adhesive interactions bring adja-
cent cell membranes into close apposition, and a network
of cytoplasmic scaffolding proteins that provide a link to
the cytoskeleton and to intracellular signaling molecules.
Barrier function is modulated under a variety of physiolog-
ical and pathological conditions, and modulation often de-
pends on the reorganization or endocytosis of one or more
TJ proteins. In some instances, the specific internalization
of a single family of TJ proteins is sufficient to cause
marked changes in barrier function (Sonoda et al., 1999).
We have examined the process by which CVB modu-
lates the barrier function of the TJ to enter polarized cells.
We find that the junction does not undergo major reorga-
nization, but that virus entry is accompanied by the
specific internalization of occludin, a transmembrane com-
ponent of the TJ. Strikingly, although occludin does not
interact directly with the virus, its expression is critical
for CVB infection—depletion of occludin prevents CVB
entry into the cytoplasm. Internalization of both CVB and
occludin are blocked by inhibitors of macropinocytosis
and require the function of the GTPases Rab34 and
Rab5, important regulators of macropinocytosis. The re-
sults suggest that internalization of occludin as well as
CVB entry occur by distinctive mechanisms that depend
on both caveolar endocytic pathways and processes
more typical of macropinocytosis.
RESULTS
Occludin Is Internalized in Response to CVB Entry
When polarized epithelial monolayers are exposed to
CVB, there is a rapid loss of TJ barrier function (within
15 min), evident as loss of transepithelial electrical resis-
tance and increased permeability to small and moderate
sized dextrans (Coyne and Bergelson, 2006). In an effort
to understand the leakiness of TJs that we observed dur-
ing virus entry, we looked for rearrangements of TJ-asso-
ciated proteins. The integral membrane protein occludinicrobe 2, 181–192, September 2007 ª2007 Elsevier Inc. 181
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Coxsackievirus Entry Requires Occludin and Rab34Figure 1. Occludin Is Internalized and
Tyrosine Phosphorylated in Response
to CVB Entry
(A) Monolayers exposed to CVB or EV7 (100
PFU/cell) were fixed and stained for ZO-1
(red) and occludin (green) 90 min p.i. Indicated
in white is the percentage of total cells contain-
ing occludin within the cytoplasm (as deter-
mined as described in the Experimental Proce-
dures).
(B) Quantification of the internalization of CVB
and occludin at 30, 60, and 90 min p.i. (shown
as the percentage of total cells containing CVB
and occludin in the cytoplasm).
(C) Monolayers exposed to CVB (100 PFU/cell)
were fixed and stained for claudin-1, JAM-1, or
CAR at 90 min p.i.
(D) Lysates of monolayers exposed to CVB
(100 PFU/cell) for the time indicated were
immunoprecipitated with anti-occludin pAb.
Immunoprecipitates were immunoblotted with
anti-phosphotyrosine 4G10 mAb, stripped,
and reprobed with anti-occludin mAb.
(E) Monolayers expressing GFP-tagged domi-
nant-negative (DN) caveolin-1 or HA-tagged
dominant-negative dynamin II were exposed
to CVB (100 PFU/cell) for 90 min, fixed, and
stained for occludin.
(F) Quantification of the effects of wild-type
(WT) or dominant-negative caveolin-1 (Cav-1), dynamin II (Dyn II), or Eps15 on occludin internalization. Data are shown as percentage of occludin
internalized compared to nontransfected controls. Data are representative of at least three independent experiments performed at least three times.
Data in (B) and (F) are presented as means ± standard deviation. *p < 0.05.moved from the TJ and relocalized to cytoplasmic vesicles
by 90 min postinfection (p.i.) (Figure 1A). Occludin internal-
ization was pronounced—94% ± 7% of cells exposed to
CVB contained occludin within cytoplasmic vesicles,
compared to only 1% ± 0.6% of control cells. This effect
was specific for CVB; occludin did not internalize in re-
sponse to the entry of another picornavirus, echovirus 7
(Figure 1A), which enters and infects polarized cells, but
does not require relocalization to the TJ (C.B.C. and
J.M.B., unpublished data). The kinetics of occludin inter-
nalization were consistent with those for CVB; virus and
occludin do not enter the cytoplasm until 60–90 min p.i.
(Figure 1B). The internalization of occludin was specific,
as other major TJ transmembrane proteins (CAR, JAM-
1, and claudin-1 [Figure 1C]) and the major cytoplasmic
TJ proteins (ZO-1 [Figure 1A], ZO-2, and ZO-3 [data not
shown]) all remained at the junction. We also observed
no internalization of the adherens junction proteins b-cat-
enin or E-cadherin (data not shown).
Tyrosine phosphorylation has been linked with in-
creased TJ permeability in polarized epithelial cells (Stad-
don et al., 1995), and occludin itself undergoes tyrosine
phosphorylation in response to a variety of stimuli (re-
viewed in Feldman et al., 2005). We observed a significant
increase in the tyrosine phosphorylation of occludin in
response to CVB (Figure 1D); no phosphorylation was
evident in cells pretreated with the general tyrosine kinase
inhibitor genistein (data not shown). In contrast, we ob-
served no change in the serine or threonine phosphor-
ylation of occludin (data not shown), modifications that182 Cell Host & Microbe 2, 181–192, September 2007 ª2007 Elhave been associated with alterations in TJ permeability
(Sakakibara et al., 1997; Wong, 1997).
Occludin internalization, like internalization of CVB
(Coyne and Bergelson, 2006), required functional caveo-
lin; dominant-negative caveolin-1 (Figures 1E and 1F)
and caveolin-1 siRNA (data not shown) blocked occludin
internalization. However, occludin internalization was not
blocked by dominant-negative dynamin II (Figures 1E
and 1F) or Eps15 (Figure 1F); as expected, both of these
dominant-negative mutants inhibited endocytosis of
transferrin (data not shown). Although the GTPase dyna-
min has been reported to be essential for the internaliza-
tion of several caveolar ligands (reviewed in Parton and Si-
mons, 2007), both occludin and CVB were internalized by
a caveolin-mediated, but dynamin-independent, process.
Occludin Is Required for CVB Internalization
At 90 min p.i., internalized occludin colocalized with cav-
eolin-1 (Figure S2B) and CVB (Figure 2A; Figure S2B) in
cytoplasmic and perinuclear vesicles. However, CVB did
not induce the internalization of claudin-1 (Figure 2B). Sur-
prisingly, depletion of occludin with siRNA blocked virus
entry (Figure 2F) and infection (Figure 2C), leaving virus
trapped at the TJ (only 11% ± 4% of virus had entered
the cytoplasm in occludin siRNA-transfected cells com-
pared to 93% ± 5% in control transfected cells). Consis-
tent with previously published data (Yu et al., 2005), we
found that occludin siRNA had no significant effect on bar-
rier properties of the TJ (Figures S1A and S1B). Occludin
siRNA also had no effect on the expression (Figure 2D)sevier Inc.
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Coxsackievirus Entry Requires Occludin and Rab34Figure 2. Occludin Is Required for CVB Entry and Infection
(A) Monolayers exposed to CVB (100 PFU/cell) were fixed and stained for VP1 (red) and occludin (green) 90 min p.i.
(B) Cells expressing EGFP-claudin-1 and mRFP-occludin were exposed to CVB (100 PFU/cell) for 90 min and stained for VP1 (blue). For clarity, VP1
staining is pseudocolored red, and fluorescent occludin is pseudocolored blue.
(C) Cells transfected with the indicated siRNA were exposed to CVB (1 PFU/cell) and stained for VP1 at 7 hr p.i.
(D) Western blot analysis of monolayers 48 hr after transfection with the indicated siRNAs. Blot was stripped and reprobed with the indicated antibody.
Densitometry was performed with ImageJ to determine efficacy (% reduction).
(E) Cells transfected with CON or OCC siRNAs were stained for CAR (in green) and occludin (in red) 48 hr after transfection.
(F) Cells transfected with control (CON) or occludin (OCC) siRNAs were exposed to CVB (100 PFU/cell) and stained for VP1 90 min p.i. The relative
amount of CVB internalized is shown in white (93% ± 8% for CON siRNA and 11% ± 4% for OCC siRNA).
(G) CHO cells transfected with control (GFP) or human CAR or occludin plasmids were exposed to S35-labeled virus (25,000 cpm). Cells were lysed
following binding at 16C, and radioactivity was determined. (Inset) Western blot analysis for CAR (top), occludin (middle), or GAPDH (bottom) in tran-
siently transfected CHO cells to control for transfection efficiency. Data are representative of at least three independent experiments performed at
least three times.
Data in (C) and (F) are shown as mean ± standard deviation. *p < 0.05.or localization of CAR (Figure 2E) or other TJ-associated
proteins (data not shown). SiRNA depletion of ZO-1, clau-
din-1, and JAM-1 had no effect on entry (data not shown)
or infection (Figure 2C). These results indicate that virus
entry from the TJ depends in some way on occludin and
suggest that virus internalization may depend on a cellular
mechanism(s) that function to internalize occludin.
To confirm that occludin was not directly interacting
with CVB, we measured CVB attachment to CHO cells
transiently transfected with human CAR or occludin. CVB
is incapable of binding to or infecting CHO cells in the
absence of receptor expression (Bergelson et al., 1997).
CHO cells expressing CAR, but not control or occludin
transfectants, bound radiolabeled CVB (Figure 2G). In
addition, CHO cells expressing CAR became infected by
CVB, whereas control or occludin transfectants did not
(data not shown). Furthermore, occludin siRNA did not
inhibit CVB binding to Caco-2 cells (Figure S1C).
Interaction of CVB with CAR induces conformational
changes in the capsid that are believed to be essential
for the uncoating process that culminates in release of
viral RNA into the cytoplasm (reviewed in Hogle, 2002).Cell Host & MNative virions, which sediment at 160S in sucrose velocity
gradients, are converted to 135S altered (A)-particles; the
release of RNA leads to the appearance of 80S empty
capsids. We have shown previously that transfection of
cells with CAR siRNA prevents A-particle formation and
prevents virus entry into the cytoplasm (trapping 160S
particles in the TJ) (Coyne and Bergelson, 2006). Although
occludin siRNA also trapped virus at the TJ (Figure 2F),
virions recovered from occludin siRNA-transfected cells
sedimented at 135S, and thus were trapped as A-parti-
cles. In control cells, virions entered the cytoplasm and
recovered virions underwent further conversion to faster-
sedimenting 80S empty capsids (Figure S1D).
Taken together, these results indicate that. although
occludin does not directly bind CVB, and is not needed for
A-particle conversion, it is nonetheless required for subse-
quent events in CVB entry.
Occludin Is Internalized in Macropinosomes
Macropinocytosis is a dynamin- and receptor-indepen-
dent endocytic mechanism responsible for nonselective
fluid and solute uptake, characterized by the closure oficrobe 2, 181–192, September 2007 ª2007 Elsevier Inc. 183
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Coxsackievirus Entry Requires Occludin and Rab34Figure 3. Occludin Is Internalized in Macropinosomes, and Inhibitors of Macropinocytosis Block CVB Entry
(A) The rate of macropinocytosis (as assessed by FITC-dextran uptake) was determined following exposure to CVB (100 PFU/cell) at the indicated
times.
(B) Cells exposed to CVB (in the absence or presence of FITC-dextran) for 90 min were fixed and stained for occludin (red), and actin (green, top) or
dextran uptake was visualized (green, bottom).
(C) Monolayers pretreated with control (DMSO), EIPA, or rottlerin were exposed to CVB (100 PFU/cell) in the presence of FITC-dextran (1 mg/ml).
At 90 min p.i., cells were fixed and the extent of FITC-dextran uptake was determined by microscopy.
(D) The rate of macropinocytosis (as determined by FITC-dextran uptake) and the percentage of cells with internalized occludin was determined in
cells treated with DMSO (no inhibitor), EIPA, or rottlerin and exposed to CVB (100 PFU/cell) for 90 min at 37C or in cells exposed to no virus. Left
y axis, rate of macropinocytosis; right y axis, occludin internalization.
(E) Monolayers treated with control (DMSO), EIPA, or rottlerin were exposed to CVB (100 PFU/cell) and stained for VP1 at 90 min p.i. The percentage of
CVB internalized is indicated in white.
(F) Cells were treated with control (DMSO), EIPA, or rottlerin prior to exposure to CVB (1 PFU/cell) and stained for VP1 at 7 hr p.i. Inhibitor was added to
cultures 1 hr prior to infection (pre-treat) or was added 90 min p.i.
(G) Cells treated with control (DMSO) or EIPA were exposed to CVB (100 PFU/cell) in the presence of FITC-dextran, then fixed and stained for occludin
(red) at 90 min p.i. Data are representative of at least three independent experiments performed three times.
Data in (A), (D), and (F) are shown as mean ± standard deviation. *p < 0.05.cell surface ruffles to form actin-coated intracellular vesi-
cles of variable size (reviewed in Swanson and Watts,
1995). CVB entry stimulated macropinocytosis by 60–90
min p.i., as evidenced by a significant increase in the up-
take of fluorophore-conjugated dextran (Figure 3A). While
we observed occludin in cytoplasmic and perinuclear cav-
eolin-1-positive vesicles (Figure S2B), we also saw occlu-
din in typical macropinosomes—large actin-coated cyto-
plasmic vesicles, heterogeneous in size, in which labeled184 Cell Host & Microbe 2, 181–192, September 2007 ª2007 Edextran was concentrated (Figure 3B). We also observed
both CVB and occludin within vesicles enriched in dextran
within the cytoplasm (Figure S2A).
Inhibitors of Macropinocytosis Block Both
Occludin Internalization and CVB Entry
Because we observed that CVB entry stimulated macropi-
nocytosis and the internalization of occludin in macropino-
somes, we examined the role of macropinocytosis inlsevier Inc.
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Coxsackievirus Entry Requires Occludin and Rab34Figure 4. Rab34 Localizes to Tight Junctions and Mediates Occludin Internalization
(A) Monolayers were exposed to CVB (100 PFU/cell) for 30 min at 37C and then fixed and stained for occludin (red) and Rab34 (green).
(B) Cells expressing wild-type EGFP-Rab34 were fixed and stained for ZO-1 (red).
(C) Colocalization of EGFP-Rab34 and DsRed-caveolin-1. Insert, 33 zoomed image.
(D) Cells expressing wild-type (WT) or constitutively active (Q111L) EGFP-Rab34 were fixed and stained for occludin (red) and ZO-1 (blue).
(E) Quantification of occludin internalization in cells transfected with a GFP control plasmid (CON), or wild-type (WT), constitutively active (Q111L)
EGFP-Rab34, dominant-negative (T66N) Rab34. Cells were either exposed to no virus (CVB) or exposed to CVB (+CVB) for 90 min at 37C.
Data are representative of at least three independent experiments performed three times. Data in (E) are shown as mean ± standard deviation.
*p < 0.05.occludin and CVB internalization. Macropinocytosis, but
not clathrin- mediated or caveolar endocytosis, is blocked
by amiloride (an inhibitor of epithelial Na+/H+ exchange)
(Meier et al., 2002; West et al., 1989), and by rottlerin (a
nonspecific inhibitor of protein kinase C and other kinases)
(Sarkar et al., 2005). Whereas EIPA (ethyl-isopropyl-ami-
loride) and rottlerin had no effect on internalization of la-
beled transferrin or cholera toxin, markers of the clathrin
and caveolin-mediated pathways (data not shown), both
inhibitors prevented occludin internalization and dextran
uptake (Figures 3C, 3D, and 3G), consistent with occludin
entry in macropinosomes. In addition, both EIPA and
rottlerin decreased CVB entry (Figure 3E) and infection
(Figure 3F), leaving virus trapped at the TJ. EIPA and rot-
tlerin did not inhibit CVB infection when added after viral
entry had occurred (90 min p.i.) (Figure 3F), suggesting
that macropinocytosis or a macropinocytosis-like process
is required for CVB internalization, not a later event in
infection. Although we have shown previously that CVB
entry depends on functional caveolin (Coyne and Bergel-
son, 2006), these result suggest a role for macropinocyto-
sis in CVB internalization and infection.
Rab34, a GTPase Required for Macropinocytosis,
Is Required for Occludin and CVB Internalization
Individual Rab GTPases are targeted to specific vesicular
compartments and control specific events in endocytosis
and endosomal trafficking (reviewed in Zerial and McBride,Cell Host & M2001). Rab34 has been linked specifically with macropino-
cytosis (Sun et al., 2003). In CVB-exposed Caco-2 cells,
we observed endogenous Rab34 associated with occlu-
din-rich membranes at the junction within 30 min p.i.
(Figure 4A), but not at the apical or basolateral surfaces
(data not shown). Endogenous (data not shown) and
wild-type EGFP-Rab34 were expressed at the TJ of unin-
fected Caco-2 cells and colocalized with the TJ marker
ZO-1 (Figure 4B). In addition to being concentrated at the
TJ, EGFP-Rab34 was localized within cytoplasmic vesi-
cles that colocalized with caveolin-1 (even in the absence
of virus) (Figure 4C). Expression of either wild-type or con-
stitutively active (Q111L) Rab34 led to pronounced inter-
nalization of occludin in resting cells (Figures 4D and
4E)—but not other junctional proteins (claudin-1, claudin-
4, CAR, JAM-1, b-catenin, E-cadherin, and ZO-1
[Figure 4D and data not shown])—and led to increased per-
meability to solutes through the paracellular space
(Figure S3C). Upon exposure to CVB, internalization of oc-
cludin was further increased in Q111L-Rab34 transfected
cells (from 43% ± 12% to 82% ± 9%) (Figure 4E).
Both dominant-negative (T66N) Rab34 and Rab34
siRNA prevented CVB-induced macropinocytosis (Fig-
ures S3A, S3B, and S3D) but did not affect either transfer-
rin or cholera toxin uptake (data not shown). Consistent
with this, occludin internalization and CVB infection were
markedly inhibited by T66N-Rab34 (Figures 4E and 5A).
In addition, Rab34 siRNA, but not Rab7 siRNA, decreasedicrobe 2, 181–192, September 2007 ª2007 Elsevier Inc. 185
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Coxsackievirus Entry Requires Occludin and Rab34Figure 5. Rab34 Is Required for CVB
Entry and Infection
(A) Monolayers expressing dominant-negative
(T66N), constitutively active (Q111L), or wild-
type forms of EGFP-Rab34 were exposed to
CVB (1 PFU/cell), and stained for VP1 at 7 hr
p.i. Data are presented as the percentage of
transfected cells expressing VP1.
(B) Western blot analysis of Caco-2 cells 48 hr
after transfection with the indicated siRNAs. All
blots were stripped and reprobed with GAPDH
pAb to control for equal protein loading. Densi-
tometry was performed with ImageJ to deter-
mine efficacy.
(C) Cells transfected with control (CON), Rab34,
Rab7, or Rab13 siRNAs were exposed to CVB
(1 PFU/cell) and stained for VP1 at 7 hr p.i.
(D) Quantification of the effects of CON, Rab34,
Rab7, and Rab13 siRNAs on CVB and occludin
internalization. Data are shown as percentage of
cells containing internalized CVB and occludin.
(E) Cells transfected with control (CON), Rab34,
or Rab13 siRNAs were exposed to CVB (100
PFU/cell) and stained for VP1 at 90 min p.i.
Data are representative of at least three inde-
pendent experiments performed three times.
Data in (A), (C), and (D) are shown as mean ±
standard deviation. *p < 0.05.CVB infection (Figure 5C), reduced CVB-induced dextran
uptake (Figure S3D), and significantly impaired occludin
and CVB entry into the cytoplasm (Figures 5D and 5E). Al-
though Rab13 has been shown to be involved in the con-
tinuous recycling of occludin from the tight junction into
the cytoplasm (Morimoto et al., 2005), we found that
Rab13 siRNA did not prevent CVB-induced macropinocy-
tosis (Figure S3D), or inhibit occludin or CVB internaliza-
tion (Figures 5D and 5E). These data suggest a role for
Rab34, a component of macropinocytosis, in the entry
of occludin and CVB.
Occludin Entry Depends on Rab5
Rab5 is an important regulator of clathrin-mediated endo-
cytosis, acting through multiple effectors to control inter-
nalization of clathrin-coated vesicles, and their fusion
with early endosomes (Zerial and McBride, 2001). Rab5
has also been reported to target caveolar vesicles to early
endosomes, and to regulate traffic between caveolae and
caveosomes: constitutively active Rab5 leads to abnormal
fusion of early endosomes and diverts caveolar traffic
from caveosomes to the enlarged endosomes (Pelkmans
et al., 2004). In addition, Rab5 signals have recently been
implicated in membrane ruffling and macropinocytosis
(Lanzetti et al., 2004; Schnatwinkel et al., 2004). We ob-
served endogenous Rab5 localized to the junction and co-
localized with internalized CVB (Figure S4A). We found
that both dominant-negative (S34N) and constitutively ac-
tive (Q79L) Rab5 blocked CVB infection (Figure 6A). Rab5
siRNA significantly decreased CVB infection (Figure 6C),
as well as virus entry into the cytoplasm (Figure 6D). While
Rab5-S34N trapped virus and occludin at the TJ and pre-
vented entry into the cytoplasm, Rab5-Q79L trapped oc-186 Cell Host & Microbe 2, 181–192, September 2007 ª2007 Ecludin and virus in large Rab5-positive vesicles (Figure 6B)
within the cell. (Other cargoes internalized by caveolin-1
mediated mechanisms [such as SV40] are unaffected by
Rab5-S34N [Pelkmans et al., 2004].) Rab5-S34N (data
not shown) and Rab5 siRNA (Figure S3D) inhibited CVB-
induced dextran uptake. Thus, Rab5 is an upstream regu-
lator of CVB-induced macropinocytosis and is required for
entry of both virus and occludin.
Rabankyrin-5, a Rab5 effector, has been shown to lo-
calize to and stimulate macropinocytosis in polarized ep-
ithelial cells (Schnatwinkel et al., 2004). We found that Ra-
bankyrin-5 localized to 82% ± 13% of macropinosomes
induced by CVB (Figure S4B), colocalized with internal-
ized CVB and occludin (Figures S4C and S4D), and siRNA
depletion of Rabankyrin-5 decreased CVB-induced mac-
ropinocytosis by 78% ± 12% (Figure S3D) and decreased
CVB infection (Figure 6E). Although Rabankyrin-5 has
been shown previously to specifically regulate apical mac-
ropinocytosis in polarized epithelial cells (Aoki et al., 1999;
Schnatwinkel et al., 2004), our results indicate that it may
also play a role in macropinocytosis from the TJ.
Ras Activation Is Required for CVB-Induced
Macropinocytosis and CVB Entry
The membrane ruffling required for macropinocytosis is
often downstream of Rac and Ras GTPase activation
(Bar-Sagi and Feramisco, 1986; Ridley et al., 1992; West
et al., 2000). Expression of wild-type Rab34 stimulated
macropinocytosis in resting cells and in response to
CVB (Figure S3B). Macropinocytosis stimulated by
Rab34 was not inhibited by a dominant-negative mutant
of Rac1 (T17N) and was not stimulated by a constitutively
active Rac1 mutant (Q61L) (Figure 7B). Furthermore,lsevier Inc.
Cell Host & Microbe
Coxsackievirus Entry Requires Occludin and Rab34Figure 6. Rab5 Is Required for CVB Entry and Infection
(A) Monolayers expressing dominant-negative (S34N), constitutively active (Q79L), or wild-type forms of EGFP-Rab5 were exposed to CVB (1 PFU/
cell) and stained for VP1 at 7 hr p.i. Data are presented as the percentage of transfected cells expressing VP1.
(B) Monolayers expressing dominant-negative (S34N), constitutively active (Q79L), or wild-type forms of EGFP-Rab5 were exposed to CVB (100 PFU/
cell) and stained for occludin (blue) and VP1 (red) at 90 min p.i.
(C) Cells transfected with control (CON) or Rab5 siRNAs were exposed to CVB (1 PFU/cell) and stained for VP1 at 7 hr p.i. (Inset) Western blot analysis
of cells 48 hr after transfection with CON or Rab5 siRNAs. Blot was stripped and reprobed with GAPDH pAb to control for equal protein loading. Den-
sitometry was performed with ImageJ to determine efficacy.
(D) Cells transfected with CON or Rab5 siRNAs were exposed to CVB (100 PFU/cell) and stained for VP1 at 90 min p.i. The relative amount of CVB
internalized is shown in white (95% ± 7% for CON siRNA and 14% ± 8% for Rab5 siRNA).
(E) Cells transfected with control (CON) or Rabankyrin-5 siRNAs were exposed to CVB (1 PFU/cell) and stained for VP1 at 7 hr p.i. (Inset) Western blot
analysis of cells 48 hr after transfection with CON or Rabankyrin-5 siRNAs. Data are representative of at least three independent experiments per-
formed three times.
Data in (A), (C), and (E) are shown as mean ± standard deviation. *p < 0.05.inhibitors of Rac1 expression and function (siRNA and
NSC23766) had no effect on Rab34-mediated dextran up-
take and internalization of occludin in response to CVB
(data not shown). We have shown previously that these
Rac inhibitors prevent CVB infection by blocking virus
movement to the TJ (Coyne and Bergelson, 2006).
Internalized EGFP-Rab34-positive macropinosomes
colocalized with coexpressed wild-type Ras in response
to CVB (Figure 7A), and expression of dominant-negative
Ras (S17N) blocked Rab34-induced macropinocytosis (by
5-fold) (Figure 7B). In addition, both constitutively active
(Q65L) and wild-type Ras expression increased the num-
ber of Rab34-positive macropinosomes (by 2-fold and
3-fold, respectively) (Figure 7B). These results suggest
that Ras and Rab34 act synergistically to promote macro-
pinocytosis in polarized Caco-2 cells, by a mechanism
that does not involve Rac.
The level of activated (GTP-bound) Ras increased
substantially at 10–20 min following exposure to CVB
(Figure 7C), internalized CVB colocalized with RasCell Host &(Figure 7E), and dominant-negative Ras decreased CVB
infection (Figure 7D) and decreased virus internalization
by 71% ± 12% (Figure 7E). Taken together, these data
suggest that Ras activation is required for CVB entry.
DISCUSSION
In the experiments reported here, we found that internali-
zation of CVB occurs by a process that combines aspects
of caveolar endocytosis with features more characteristic
of macropinocytosis. We found that entry of CVB de-
pended on the TJ protein occludin, and that virus induces
internalization of occludin within macropinosomes. Both
CVB entry (Coyne and Bergelson, 2006) and occludin in-
ternalization (this report) required caveolin but were inde-
pendent of dynamin; both were blocked by drugs that
inhibit macropinocytosis; and both required Rab34, a
GTPase implicated in macropinosome formation, and
Rab5, a GTPase known to stimulate macropinocytosis.Microbe 2, 181–192, September 2007 ª2007 Elsevier Inc. 187
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(A) Colocalization in macropinosomes (arrows) of EGFP-Rab34 (green) and constitutively active Ras (red).
(B) Caco-2 monolayers were transfected with plasmids encoding wild-type EGFP-Rab34, as well as constitutively active, or dominant-negative, Ras
or Rac. Macropinosomes (defined as actin-coated Rab-34-positive vesicles) were counted. The graph shows the mean ± standard deviation for four
monolayers. NT, monolayers transfected with Rab 34 without Rac/Ras. *p < 0.05 compared to NT.
(C) Monolayers exposed to CVB (100 PFU/cell) were lysed (at 0, 10, 20, or 30 min p.i.), and GTP-bound Ras was isolated. Equal amounts of whole-cell
lysate were blotted to evaluate total Ras expression.
(D) Monolayers expressing dominant-negative (S17N) or wild-type forms of Ras were exposed to CVB (1 PFU/cell) and stained for VP1 at 7 hr p.i. Data
are presented as the percentage of transfected cells expressing VP1.
(E) Monolayers expressing dominant-negative (S17N) or wild-type forms of Ras were exposed to CVB (100 PFU/cell) and stained for VP1 (red) and Ras
(green) 90 min p.i. The relative amount of CVB internalized is shown in white (89% ± 14% for WT Ras and 26% ± 12% for DN Ras). Data are repre-
sentative of at least three independent experiments performed three times.
Data in (A) and (D) are shown as mean ± standard deviation. *p < 0.05.The molecular mechanisms underlying macropinocyto-
sis in polarized epithelia are poorly defined. Although mac-
ropinocytosis from the apical membrane has been linked
to Src kinase activity (Mettlen et al., 2006), we found that
a Src siRNA had no effect on CVB entry (Coyne and Ber-
gelson, 2006) or occludin internalization (data not shown)
from the TJ, suggesting that different mechanisms control
macropinocytosis from the apical and lateral domains.
In fibroblasts, Rab34-mediated macropinocytosis has
been shown to require the activity of Rac and the actin nu-
cleation factor WAVE2 (Sun et al., 2003). In Caco-2, cells,
we found that Rab34-induced macropinocytosis was Rac
independent (Figure 7B) and was unaffected by a WAVE2
siRNA (data not shown). Although Rac was not required
for macropinocytosis, CVB-induced activation of Ras
was essential for virus entry and infection as well as for
macropinocytosis induced by Rab34 (Figures 7B, 7D,
and 7E). Ras-mediated signals have also been implicated188 Cell Host & Microbe 2, 181–192, September 2007 ª2007 Elsin Rab5-dependent macropinocytosis (Lanzetti et al.,
2004).
Few viruses appear to utilize macropinocytosis to gain
entry into host cells. Human immunodeficiency virus-1
(HIV-1) enters both macrophages and brain endothelium
by macropinocytosis (or a macropinocytosis-like process)
(Liu et al., 2002; Marechal et al., 2001). Adenovirus type 2
(Ad2) utilizes Rac-dependent macropinocytosis not for
entry into the host cell, but rather for pH-activated escape
from endosomes into the cytoplasm (Meier et al., 2002).
Although both Ad2 and CVB induce macropinocytosis,
and both interact with CAR, CAR itself does not appear
to be essential for induction. In the case of Ad2, macropi-
nocytosis depends on virus interaction with its av-integrin
coreceptor (Meier et al., 2002), and we have found that
CVB-induced macropinocytosis of occludin was not in-
hibited by CAR siRNA (data not shown). It may be that
CAR and occludin provide different, but equally important,evier Inc.
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ing (Coyne and Bergelson, 2006), and occludin may serve
as a scaffold to recruit and anchor signaling or regulatory
molecules in the vicinity of virus entry.
If macropinocytosis is required for CVB and occludin
entry, why is caveolin also necessary? The pinching off
of caveolar vesicles to internalize caveolar cargoes such
as SV40 and cholera toxin depend on dynamin (reviewed
in Parton and Simons, 2007), but the internalization of both
occludin and CVB occurred even in the presence of dom-
inant-negative dynamin (Figures 1E and 1F; Coyne and
Bergelson, 2006). Caveolae have been implicated in the
internalization of cargos such as bacteria and lympho-
cytes that are too large (>1 mm for bacteria and > 7 mm for
lymphocytes) to be contained within a single caveolar ves-
icle (60–80 nm) (Millan et al., 2006; Mulvey and Hultgren,
2000). The internalization of large cargoes likely requires
membrane rearrangements on a scale characteristic of
macropinosome or phagosome formation. Caveolin-1
knockout mice display phagocytic defects, consistent
with a role for caveolin-1 in endocytic processes distinct
from internalization of typical caveolar vesicles (Li et al.,
2005). Taken together, these observations have led to
the suggestion that caveolin may serve to regulate a vari-
ety of endocytic processes (Parton and Simons, 2007).
The mechanism of CVB entry may be distinct from those
described for other caveolin-dependent viruses because
the virus enters through the TJ. TJs themselves share
characteristics of lipid rafts, and TJ proteins have been
shown to associate with caveolin-rich membranes (Nusrat
et al., 2000b). However, the flask-like invaginations typical
of caveolae are located primarily at the basolateral surface
of resting polarized epithelial cells and are not generally
observed at the TJ (Lahtinen et al., 2003; Mora et al.,
1999; Vogel et al., 1998). In previous experiments, we
did not detect a concentration of caveolin-1 at the TJ of
resting Caco-2 cells. However, CVB interaction with DAF
on the cell surface rapidly induced the phosphorylation
of caveolin-1 on tyrosine 14 and the appearance of phos-
phorylated caveolin at the TJ, which was necessary for
CVB entry (Coyne and Bergelson, 2006). Phosphorylation
of tyrosine 14 of caveolin-1 has been associated with the
formation and fusion of caveolin-derived vesicles (Aoki
et al., 1999). Nonetheless, it remains unclear whether
TJ-associated caveolin-1 leads to the formation of typical
caveolae, or whether it may serve another function. The
physical interaction of caveolin with cellular membranes
may facilitate membrane perturbations associated with
the formation and/or closure of macropinosomes at the
junction. Alternatively, caveolin-1 may act as an anchor
to concentrate signaling molecules or other effector mol-
ecules in the area of the TJ.
The TJ is a complex of transmembrane proteins (such
as occludin) and cytoplasmic scaffolding proteins, both
of which serve to link the cell membrane to the actin cyto-
skeleton and an array of signaling molecules. With such an
elaborate network of proteins concentrated at the TJ, why
is occludin specifically required for CVB infection? Occlu-
din is not involved in CVB attachment, or in the relocaliza-Cell Host &tion of CVB to the TJ, but an occludin siRNA trapped virus
at the TJ, suggesting that occludin regulates a key aspect
of CVB entry. Occludin interacts directly with signaling
molecules (Basuroy et al., 2006; Chen et al., 2002; Nusrat
et al., 2000a), including the p85 subunit of PI3K, a known
mediator of phagocytosis and macropinocytosis (re-
viewed in Lindmo and Stenmark, 2006). In addition, occlu-
din interacts with caveolin-1 (Nusrat et al., 2000b), sug-
gesting a possible functional connection. Although
occludin has never been implicated as a regulator of en-
docytosis, it is possible that it promotes CVB entry by re-
cruiting caveolin or other regulatory molecules to the TJ.
CVB enters polarized epithelial cells by a complex
mechanism. The complexity may be due to the particular
properties of polarized intestinal cells, or to the fact that
CVB uses a receptor that is itself a component of the TJ.
At least three viruses initiate infection by attaching to re-
ceptors within the junctional complex of polarized epithe-
lia. Like CVB (and adenoviruses, which also bind to CAR),
reoviruses (Barton et al., 2001) and members of the her-
pesvirus family (Geraghty et al., 1998) interact with recep-
tors that are normally sequestered within junctions. In ad-
dition, recent data support a role for claudin-1 (a
transmembrane component of the TJ with structural sim-
ilarities to occludin) in a postattachment event associated
with the entry of hepatitis C virus (HCV) (Evans et al.,
2007). Claudin-1 is not known to bind HCV, and HCV in-
fection may also require interaction of the virus with two
coreceptors—the tetraspanin CD81 (Pileri et al., 1998)
and the scavenger receptor class B member I (Scarselli
et al., 2002)—neither of which is sufficient to promote
infection. It is therefore conceivable that claudin-1 and
occludin facilitate virus internalization by similar mecha-
nisms. Defining the mechanism of CVB entry is likely to
provide insights into the physiology of tight junction regu-
lation as well as the entry mechanisms of other viral
pathogens.
EXPERIMENTAL PROCEDURES
Cells and Viruses
Caco-2 cells, cultured as described (Coyne et al., 2004), were plated in
collagen-BD BioCoat Collagen I 8-well culture slides (BD Biosciences,
San Jose, CA) at a density of 1 3 105 cells/well for immunofluores-
cence microscopy and in 12 mm Transwell-Col inserts (0.4 m pore
size) (Costar) at a density of 53 105 cells for permeability studies. Cells
were grown a minimum of 48 hr prior to study.
CVB3-RD (Reagan et al., 1984) was originally obtained from Dr. Ri-
chard Crowell (Hahnemann University). Viruses were expanded by
growth in HeLa cells and concentrated by ultracentrifugation through
a sucrose cushion, and titers were determined by plaque assay on
HeLa cells. Immunofluorescence experiments tracking virus entry
were performed at a multiplicity of 100 PFU per cell. Experiments
measuring productive virus infection were performed with 1 PFU/cell.
The typical picornavirus particle/PFU ratios is approximately 200
(Rueckert, 1996).
Antibodies
Mouse anti-enterovirus VP1 (Ncl-Entero) was obtained from Novocas-
tra Laboratories (Newcastle upon Tyne, UK). Monoclonal antibodies
against ZO-1 and occludin and polyclonal antibodies against occludin,
ZO-1, JAM, and claudin-1 were purchased from Invitrogen (Carlsbad,Microbe 2, 181–192, September 2007 ª2007 Elsevier Inc. 189
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were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Poly-
clonal Rab5 and Rab7 antibodies were purchased from Sigma (St.
Louis, MO). Monoclonal anti-phosphotyrosine antibody (4G10) was
purchased from Upsate Biotechnology (Lake Placid, NY). Polyclonal
anti-Rabankyrin-5 was provided by Marino Zerial (Max Planck Institute
of Molecular Cell Biology and Genetics). Alexa Fluor-conjugated sec-
ondary antibodies were purchased from Invitrogen (Carlsbad, CA).
Pharmacological Inhibitors
The amiloride analog ethyl isopropyl amiloride (EIPA) and rottlerin were
purchased from Sigma and were used at 50 mM and 1 mM, respec-
tively. Monolayers were pretreated with inhibitors for 1 hr at 37C,
washed, and incubated with CVB at a multiplicity of 100 PFU/cell (viral
entry studies) or 1 PFU/cell (viral infection studies) in virus-binding
buffer (DMEM supplemented with 1 mM HEPES) containing inhibitor
for 1 hr at 4C. Following washing, virus entry/infection, dextran up-
take, and occluding internalization were initiated by shifting cells to
37C in medium containing inhibitor. (Although toxicity can be associ-
ated with long-term exposure to EIPA, we did not observe an increase
in apoptosis [as assessed by Annexin-V staining], necrosis or loss of
membrane integrity [as assessed by propidium iodide staining], or de-
crease in cell number [as assessed by light microscopy] over the
course of treatment.)
Plasmids, siRNAs, and Transfections
Wild-type GFP-caveolin-1 and dominant-negative caveolin-1-GFP
(Pelkmans et al., 2001) were provided by Ari Helenius and Lucas Pelk-
mans (Swiss Federal Institute of Technology). HA-tagged wild-type or
dominant-negative dynamin (van der Bliek et al., 1993) were provided
by Sandra Schmid (Scripps Research Institute). mRFP1-occludin and
EGFP-claudin-1 plasmids have been described (Shen and Turner,
2005). YFP-Rabankyrin-5 and wild-type, S34N, and Q79L Rab5 plas-
mids were provided by Marino Zerial (Max Planck Institute of Molecular
Cell Biology and Genetics). EGFP-tagged Rab34 constructs were pro-
vided by Wanjin Hong (Institute of Molecular and Cell Biology, Singa-
pore). All Ras constructs were purchased from Upstate Biotechnology.
Rab13 SMARTpool siRNA reagent was obtained from Dharmacon
(Chicago, IL). Rab7 siRNA (sc-29460) was purchased from Santa
Cruz Biotechnology. Double-stranded siRNAs targeted against human
claudin-1 (sense, 50-UUCCAUAUUGAUGAAGAUGTT-30), JAM-1 (50-
AGGCAUCACUAUCCCAUC UUUTT-30), occludin (50-GCAGCCAUG
UACUCUUCACTT-30), ZO-1 (50-AAAUGAGGAUUAU CUCGUCTT-30),
and Rabankyrin-5 (50-CUCUUUAGUGG AAGACAAGUU-30 ) were
synthesized by Integrated DNA Technologies (Coralville, IA).
Transfection of Caco-2 and CHO cells with siRNAs and/or plasmids
was performed using the Nucleofector System (Amaxa, Gaithersburg,
MD) according to the manufacturer’s protocol. Following transfection,
cells were plated at a density of 1 3 105 cells/well in collagen-coated
chamber slides and used for virus infection 48 hr later. Transfection
efficiencies with plasmids (as determined by GFP expression) were
60%–90%, and transfection with Cy5-labeled siRNA was 80%–100%.
Immunofluorescence Microscopy
Monolayers were exposed to CVB in virus-binding buffer for 1 hr at
4C, then washed, and virus entry was initiated by shifting cells to
37C. In all experiments, cells were fixed and permeabilized before
staining with ice-cold methanol/acetone (3:1) for 5 min at room tem-
perature (RT) or 4% paraformaldehyde followed by permeabilization
with 0.1% Triton X-100 in PBS. Cells were incubated with the indicated
primary antibodies for 1 hr at RT, washed, incubated with Alexa Fluor
(AF)-594- or AF-488-conjugated secondary antibodies for 30 min at
RT, washed, and mounted with Vectashield (Vector Laboratories, Bur-
lingame, CA) containing 40,6-diamidino-2-phenylindole (DAPI). Images
were captured with a BX51 Olympus fluorescence microscope
(Melville, NY) or a LeicaTCS 4D laser-scanning confocal microscope
(Leica, Exton, PA). Images were captured as follows: to capture the red
channel (AF 594), excitation/emission filters were set at band pass190 Cell Host & Microbe 2, 181–192, September 2007 ª2007 Els543 nm/long pass 560 nm; green channel (AF 488) images were cap-
tured with filters set at band pass 488 nm/long pass 505 nm. For
three-dimensional analysis, XZ or YZ series stacks were acquired at
0.5 mm intervals through the total thickness of the cell monolayer
(10 mm). Scale bar in figures is 10 mm.
Images were processed and quantified using the ImageJ program
(http://rsb.info.nih.gov/ij/). Quantification of CVB internalization was
determined by measuring the relative fluorescence intensity profiles
(in arbitrary units) of CVB in the cytoplasm. Internalization was calcu-
lated according to the following equation: internalization = (FC)/(FTOTAL)
3 100%, where FC is the relative fluorescence of CVB in the cytoplasm
and FTOTAL is the total CVB fluorescence. Calculations were based on
50 cells. Occludin internalization was determined in two ways: cells
containing occludin within the cytoplasm were counted, and internal-
ization was expressed as a percentage of the total cell number; alter-
natively, the fluorescence intensity of occludin within the cytoplasm
was measured, and internalization was expressed as described above
for CVB. Calculations were based on approximately 50 cells. For quan-
tification of dextran uptake, the number of cells containing FITC-dex-
tran was determined (for approximately 500 cells).
Immunoblots
Cell lysates were prepared with RIPA buffer (50 mM Tris-HCl [pH 7.4];
1% NP-40; 0.25% sodium deoxycholate; 150 mM NaCl; 1 mM EDTA;
1 mM phenylmethanesulfonyl fluoride; 1mg/ml aprotinin, leupeptin, and
pepstatin; 1 mM sodium orthovanadate), and insoluble material was
cleared by centrifugation for 5 min at 4C. Lysates (30 mg) was loaded
onto 4%–15% Tris-HCl gels (Bio-Rad, Hercules, CA) and transferred
to polyvinylidene difluoride membranes. Membranes were blocked
overnight in 5% nonfat dry milk or bovine serum albumin, probed
with antibodies, and developed with horseradish peroxidase-conju-
gated secondary antibodies (Jackson ImmunoResearch, West Grove,
PA), and ECL reagents (Amersham Biosciences, Piscataway, NJ).
Ras Activation Assay
Monolayers were lysed in magnesium lysis buffer (Upstate Biotechnol-
ogy) supplemented with 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM
sodium vanadate, and 1 mM sodium fluoride. To precipitate GTP-
bound Ras, lysates (100–200 mg) were incubated with Raf-1 (RBD)-
agarose for 1 hr at 4C. After centrifugation, beads were washed in
lysis buffer and then heated at 95C for 10 min in Laemmli sample
buffer. Supernatant was run on 15% Tris-HCl gels (Bio-Rad) and
probed as described above. Total lysates (30 mg) were also immuno-
blotted to measure the total amount of Ras.
Statistical Analysis
Data are presented as mean ± standard deviation. A one-way analysis
of variance (ANOVA) and Bonferroni’s correction for multiple compar-
isons were used to determine statistical significance (p < 0.05).
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures and four supplemental figures and can be found with this article
online at http://www.cellhostandmicrobe.com/cgi/content/full/2/3/
181/DC1/.
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